![Huan Ming Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Huan Ming Chen
Vorstandsvorsitzender bei Shanghai Zhimeng Biopharma, Inc.
Profil
Huan Ming Chen is the founder of Shanghai Zhimeng Biopharma, Inc. He holds the title of President & Chief Executive Officer since the company's founding in 2015.
Aktive Positionen von Huan Ming Chen
Unternehmen | Position | Beginn |
---|---|---|
Shanghai Zhimeng Biopharma, Inc.
![]() Shanghai Zhimeng Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Shanghai Zhimeng Biopharma, Inc. is a clinical-stage biopharmaceutical company located in the resource-rich Zhangjiang High Tech Park of Shanghai, China. The Chinese company is committed to developing innovative drugs for the treatment of chronic hepatitis B (CHB) and severe neurological diseases with significant unmet medical needs. Founded in 2017, Zhimeng Pharmaceutical Technology Co., Ltd. is a biotechnology company dedicated to the development of drugs for the treatment of CHB and related liver diseases. The company was founded by Huan Ming Chen, Zhi Jun Zhang, and Bo Liang, with Huan Ming Chen serving as the CEO since 2015. | Vorstandsvorsitzender | 26.10.2015 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Shanghai Zhimeng Biopharma, Inc.
![]() Shanghai Zhimeng Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Shanghai Zhimeng Biopharma, Inc. is a clinical-stage biopharmaceutical company located in the resource-rich Zhangjiang High Tech Park of Shanghai, China. The Chinese company is committed to developing innovative drugs for the treatment of chronic hepatitis B (CHB) and severe neurological diseases with significant unmet medical needs. Founded in 2017, Zhimeng Pharmaceutical Technology Co., Ltd. is a biotechnology company dedicated to the development of drugs for the treatment of CHB and related liver diseases. The company was founded by Huan Ming Chen, Zhi Jun Zhang, and Bo Liang, with Huan Ming Chen serving as the CEO since 2015. | Health Technology |